Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-07-24 00:00:00 ET · period of report 2024-07-22 · accession 0000950170-24-086173 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-24 | 2024-07-22 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $2.48 | +68.2K | 185.1K | +58% | +$169.2K |
| D | 2024-07-24 | 2024-07-22 | WVE | Vargeese Chandra | See Remarks | M - OptEx | $0.00 | -68.2K | 75.3K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-07-22 | M | A | 68,210 | $2.48 | 185,061 | D | — | — | (F1) Includes 2,559 ordinary shares acquired on July 14, 2023, 4,135 ordinary shares acquired on January 14, 2024, and 3,533 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan. |
| 2 | Derivative | Share Option (right to buy) | 2024-07-22 | M | D | 68,210 | $0.00 | 75,332 | D | $2.48 · — to 2025-03-10 | 68,210 Ordinary Shares | (F2) The share options that were exercised via cash purchase in this reportable transaction were fully vested. |